Skip to main content

Advertisement

Log in

Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Although the outcome of surgery for locally advanced pancreatic cancer remains poor, it is improving, with 5-year survival up to about 10% in Japan. The preliminary results of our multi-institutional randomized controlled trial revealed better survival after surgery than after radiochemotherapy. We report the final results of this study after 5 years of follow-up.

Methods

Patients with preoperative findings of pancreatic cancer invading the pancreatic capsule without involvement of the superior mesenteric or common hepatic arteries, or distant metastasis, were included in this randomized controlled trial, with their consent. If the laparotomy findings were consistent with these criteria, the patient was randomized to a surgery group or a radiochemotherapy group (5-fluorouracil 200 mg/m2/day and 5040 Gy radiotherapy). We compared the mean survival time, 3-and 5-year survival rates, and hazard ratio.

Results

The surgery and radiochemotherapy groups comprised 20 and 22 patients, respectively. Patients were followed up for 5 years or longer, or until an event occurred to preclude this. The surgery group had significantly better survival than the radiochemotherapy group (P < 0.03). Surgery increased the survival time and 3-year survival rate by an average of 11.8 months and 20%, respectively, and it halved the instantaneous mortality (hazard) rate.

Conclusion

Locally invasive pancreatic cancer without distant metastases or major arterial invasion is treated most effectively by surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnke LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977;186:42–50.

    Article  PubMed  CAS  Google Scholar 

  2. Nagakawa T, Nagamori M, Futakami F, Tsukioka Y, Kayahara M, Ohta T, et al. Results of extensive surgery for pancreatic carcinoma. Cancer 1996;77:640–645.

    Article  PubMed  CAS  Google Scholar 

  3. Imaizumi T, Hanyu F, Harada N, Hatori T, Fukuda A. Extended radical Whipple resection for cancer of the pancreatic head: operative procedure and results. Dig Surg 1998;15:299–307.

    Article  PubMed  CAS  Google Scholar 

  4. Yamamoto M, Ohashi O, Saitoh Y. Japan Pancreatic Cancer Registry: current status. Pancreas 1998;16:238–242.

    Article  PubMed  CAS  Google Scholar 

  5. Pancreatic Cancer Registration Committee of the Japan Pancreas Society. Report of a nation-wide survey of pancreatic cancer in 1999 (Japanese). Suizou (J Jap Pancreas Soc) 2001;16:115–147.

    Google Scholar 

  6. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430–435.

    Article  PubMed  CAS  Google Scholar 

  7. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.

    Article  PubMed  CAS  Google Scholar 

  8. Livingston EH, Welton ML, Reber HA. Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol 1991;9:153–157.

    PubMed  CAS  Google Scholar 

  9. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59–66.

    Article  PubMed  CAS  Google Scholar 

  10. Meyer W, Jurowich C, Reichel M, Steinhauser B, Wunsch PH, Gebhardt C. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today 2000;30:582–587.

    Article  PubMed  CAS  Google Scholar 

  11. Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 1999;29:16–22.

    Article  PubMed  CAS  Google Scholar 

  12. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995;76:1671–1677.

    Article  PubMed  CAS  Google Scholar 

  13. Schafer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 2002;236:137–148.

    Article  PubMed  Google Scholar 

  14. Kelsen D. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer. Semin Oncol 1994;21:58–66.

    PubMed  CAS  Google Scholar 

  15. Fennelly D, Kelsen DP. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas. Hepatogastroenterology 1996;43:356–362.

    PubMed  CAS  Google Scholar 

  16. Riess H, Htun P, Loffel J, Huhn D. Chemotherapy for patients with adenocarcinoma of the pancreas. Recent Results Cancer Res 1996;142:415–424.

    PubMed  CAS  Google Scholar 

  17. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899–903.

    PubMed  CAS  Google Scholar 

  18. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865–867.

    Article  PubMed  CAS  Google Scholar 

  19. Moertel CG, Frytak S, Hahn RG, O’Connell MJ, Reitemeier RJ, Rubin J, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil), and high dose radiation+5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705–1710.

    Article  PubMed  CAS  Google Scholar 

  20. Imamura M, Doi R, Imaizumi T, Funakoshi A, Wakasugi H, Sunamura M, et al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 2004;136:1003–1011.

    Article  PubMed  Google Scholar 

  21. Japan Pancreas Society. Classification of pancreatic carcinoma (English edition). 1st ed. Tokyo: Kanehara, 1996.

    Google Scholar 

  22. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions — standardizing data on outcomes. N Engl J Med 1998;339:380–386.

    Article  PubMed  CAS  Google Scholar 

  23. Tan LB, Murphy R. Shifts in mortality curves: saving or extending lives? Lancet 1999;354:1378–1381.

    Article  PubMed  CAS  Google Scholar 

  24. Beard SM, Holmes M, Price C, Majeed AW. Hepatic resection for colorectal liver metastases: a cost-effectiveness analysis. Ann Surg 2000;232:763–776.

    Article  PubMed  CAS  Google Scholar 

  25. Karrison TG. Use of Irwin’s restricted mean as an index for comparing survival in different treatment groups — interpretation and power considerations. Control Clin Trials 1997;18:151–167.

    Article  PubMed  CAS  Google Scholar 

  26. Irwin JO. The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice. J Hygiene 1949;47:188–189.

    Article  CAS  Google Scholar 

  27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.

    Article  Google Scholar 

  28. Kurihara M, Shimizu H, Tsuboi K, Kobayashi K, Murakami M, Eguchi K, et al. Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psychooncology 1999;8:355–363.

    Article  PubMed  CAS  Google Scholar 

  29. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999;117:1464–1484.

    Article  PubMed  CAS  Google Scholar 

  30. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 1999;189:1–7.

    Article  PubMed  CAS  Google Scholar 

  31. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995;221:43–49.

    Article  PubMed  CAS  Google Scholar 

  32. Glasgow RE, Mulvihill SJ. Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med 1996;165:294–300.

    PubMed  CAS  Google Scholar 

  33. Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000;232:786–795.

    Article  PubMed  CAS  Google Scholar 

  34. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200–1210.

    Article  PubMed  CAS  Google Scholar 

  35. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007;297:267–277.

    Article  PubMed  CAS  Google Scholar 

  36. Inoue K, Hiraoka T, Kanemitsu K, Takamori H, Tsuji T, Kawasuji M. Onset of liver metastasis after histologically curative resection of pancreatic cancer. Surg Today 2006;36:252–256.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doi, R., Imamura, M., Hosotani, R. et al. Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial. Surg Today 38, 1021–1028 (2008). https://doi.org/10.1007/s00595-007-3745-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-007-3745-8

Key words

Navigation